J. Mark Lievonen, C.M.

JML Advisory Services

Canada’s COVID-19 Vaccine Task Force

Mark Lievonen is the Principal of JML Advisory Services and the former President of Sanofi Pasteur Limited, the Canadian vaccine division of Sanofi. He is a Senior Fellow and Adjunct Lecturer at the IHPME at the Dalla Lana School of Public Health, and a Co-Chair of Canada’s COVID-19 Vaccine Task Force.

Mark served as Chair of the Board of Directors of BIOTECanada, Rx&D (now Innovative Medicines Canada), the Ontario Genomics Institute, the Markham Stouffville Hospital Foundation and the Centre for the Advancement of Health Innovation, as Vice-Chair of the Ontario Institute for Cancer Research, and as a member of the Board of Oncolytics Biotech, Acerus Pharmaceuticals, Quest PharmaTech, the Public Policy Forum and York University. Currently, he is a member of the Board of Sona Nanotech Inc., OncoQuest Pharmaceuticals Inc., Biome Grow Inc. and the Gairdner Foundation.

Mark was appointed to the Order of Canada, named a Chevalier de l’Ordre National de Merite by the Government of France, and inducted into the Canadian Healthcare Marketing Hall of Fame. He has received Lifetime Achievement Awards from Life Sciences Ontario and the Pharmaceutical Sciences Group, and the Canada Medal from The Chemical Institute of Canada.

Mark holds a BBA in accounting and a MBA in finance and marketing from the Schulich School of Business, and received a Honourary Doctor of Laws from York University. He is a Chartered Professional Accountant and was elected a Fellow of the Institute of Chartered Accountants of Ontario.